In addition, the CTNNA2 mutation has been shown to be associated with the prognosis of gastric cancer, laryngeal cancer, and pancreatic ductal cancer (Fanjul-Fernandez et al., 2013; Wang et al., 2014; Rizzato et al., 2016). Here, CTNNA2 is linked to gastric cancer.